Immuron (ASX:IMC) plans to issue $4.1m worth of options exercisable at $0.04 per share - just under twice the current trading price of the company's shares. [ + ]

Adelaide-based Bioconst has begun developing a line of genetically modified fluorescent flowers that produce a protein that glow when exposed to a proprietary UV LED. [ + ]

Professor Johnson Mak is working to understand how HIV functions with the hope of revealing weaknesses that could enable effective treatments and vaccines. [ + ]

CSIRO and the United States’ National Oceanic and Atmospheric Administration (NOAA) today signed a series of agreements that bring together the scientific capabilities of two global leaders in marine and atmospheric research. [ + ]

University of Adelaide researchers have discovered that recent climate change is causing the leaves of some Australian plants to narrow in size. [ + ]

Concern is growing in Australia about attempts by various governments to introduce stronger intellectual property (IP) right enforcement standards. In a major vote on Wednesday night, the European parliament rejected the new Anti-Counterfeiting Trade Agreement (ACTA). [ + ]

AusBiotech is pleased to announce that the July edition of AusBiotech’s journal, Australasian Biotechnology, is now published, featuring a special investment edition. [ + ]

Cancer Therapeutics has revealed positive preclinical results from a trial of CTx-294886 and that it has produced a new small molecule screening platform. [ + ]

Several biotech and pharmaceutical industry associations have banded together to call for the recent TGA fee hike to be wound back. [ + ]

Last night’s announcement of the discovery of the Higgs boson, or ‘God particle’, will collide with art and society on Sunday 8 July. ‘Colliding Ideas: Art, Society and Physics’ is a free public symposium, to be held at RMIT University in Central Melbourne from noon-5 pm. [ + ]

At a seminar held at CERN yesterday as a curtain raiser to the year’s major particle physics conference, ICHEP2012 in Melbourne, ATLAS and CMS experiments presented their latest preliminary results in the search for the long-sought Higgs particle. [ + ]

Sirtex Medical (ASX:SRX) recorded strong quarterly and full-year growth for dose sales of its SIR-Spheres targeted radioactive liver cancer treatments. [ + ]

Starpharma (ASX:SPL) is researching expanding its dendrimer nanotechnology platform to a wide range of drug classes besides its initial focus on chemotherapeutics. [ + ]

QRxPharma will meet with the FDA in August to discuss whether more trials of MoxDuo IR are required or existing data reanalysed, but CEO John Holaday is confident its application is “more than adequate for approval”. [ + ]

Professor Ryan Lister, an expert in the use of advanced DNA sequencing technologies and computational biology to understand how complex biological systems work, has been appointed to The University of Western Australia (UWA). [ + ]